ClinicalTrials.gg
Drug

Brivaracetam clinical trials

Also written Briviact and UCB34714.

studies test it
48
open now
3
in phase 3
26
first study started
2002

How each study uses brivaracetam is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the brivaracetam studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
18 Feb 2016 · BRIVIACT · NDA 205836 (FDA, Drugs@FDA)
European Union
13 Jan 2016 · Briviact (in Italy: Nubriveo) · EMEA/H/C/003898 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Brivaracetam
33
BRV
4
Brivaracetam Film-coated tablet
2
Brivaracetam oral solution
2
Brivaracetam 25 mg
2

Brand

Briviact
15

Development codes

UCB34714
8

Studies by the year they started

48 studies that test it; most in 2021 (5)

Studies that test brivaracetam, by start year
YearStudies
20021
20041
20054
20063
20073
20084
20101
20114
20123
20141
20151
20173
20181
20192
20215
20224
20231
20244
20251
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
11
Phase 2
10
Phase 3
26
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 42 · Other 6

UCB Pharma (16) · UCB Biopharma SRL (10) · UCB Pharma SA (7) · UCB Biopharma S.P.R.L. (3) · University of Minnesota (2) · UCB BIOSCIENCES, Inc. (2) · Jiangxi Qingfeng Pharmaceutical Co. Ltd. (1) · Muhammad Aamir Latif (1)

Often tested with

Tested in the same studies.

Levetiracetam (3) · BRV 25 (1) · BRV 50 (1)

Studies

Open first, then newest update. How each study uses brivaracetam is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 48

See all 48 studies that test brivaracetam →

Given beside what is tested · 1 — brivaracetam is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with brivaracetam

Codes

What other systems call brivaracetam · ClinicalTrials.gg INT004618

  • MeSH (NLM) C482793brivaracetamConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) U863JGG2IABRIVARACETAMConfirmed FDA, NLM, Wikidata
  • RxNorm 1739745Confirmed FDA, Wikidata
  • Wikidata Q408099brivaracetamConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C65270BrivaracetamOne source FDA
  • DrugBank DB05541One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.